학술논문

Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery
Document Type
Report
Source
Biomaterials. Nov, 2007, Vol. 28 Issue 31, p4619, 9 p.
Subject
Image processor
Pharmacy -- Analysis
Acetone -- Analysis
Universities and colleges -- Analysis
Porosity -- Analysis
Image processing -- Equipment and supplies
Image processing -- Analysis
Drug delivery systems -- Analysis
Drugs -- Vehicles
Drugs -- Analysis
Biological products -- Analysis
Rain and rainfall -- Analysis
Lactose -- Analysis
Language
English
ISSN
0142-9612
Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.biomaterials.2007.07.006 Byline: Yiwei Wang (a), Hsin-I Chang (a), David F. Wertheim (b), Allan S. Jones (c), Chris Jackson (d), Allan G.A. Coombes (a) Keywords: Biocomposite; Polycaprolactone; Protein delivery; Porosity; Scaffold; Micro-CT Abstract: Microporous, biocomposite matrices comprising a continuous phase of poly(I[micro]-caprolactone) (PCL) and a dispersed phase of lactose or gelatin particles with defined size range (45-90, 90-125 and 125-250[mu]m) were produced by precipitation casting from solutions of PCL in acetone. Scanning electron microscopy (SEM) analysis revealed a characteristic surface morphology of particulates interspersed amongst crystalline lamellae of the polymer phase. Rapid release of around 80% of the lactose content occurred in PBS at 37[degrees]C in 3 days, whereas biocomposites containing gelatin particles of size range 90-125 and 125-250[mu]m, respectively, displayed gradual and highly efficient release of around 90% of the protein phase over 21 days. A highly porous structure was obtained on extraction of the water-soluble phase. Micro-computed tomography (Micro-CT) and image analysis enabled 3-D visualisation and quantification of the internal pore size distribution. A maximum fractional pore area of 10.5% was estimated for gelatin-loaded matrices. Micro-CT analysis confirmed the presence of an extensive system of macropores, sufficiently connected to permit protein diffusion, but an absence of high volume, inter-pore channels. Thus tissue integration would be confined to the matrix surface initially if the designs investigated were used as tissue-engineering scaffolds, with the core potentially providing a depot system for controlled delivery of growth factors. Author Affiliation: (a) Faculty of Pharmacy, University of Sydney, NSW 2006, Australia (b) Faculty of Computing, Information Systems and Mathematics, Kingston University, London, Kingston upon Thames, Surrey KT1 2EE, UK (c) Australian Key Centre for Microscopy and Microanalysis, University of Sydney, NSW 2006, Australia (d) Sutton Arthritis Research Laboratories, Royal North Shore Hospital, University of Sydney, NSW 2065, Australia Article History: Received 8 March 2007; Accepted 2 July 2007